Jeffrey A Meckler
CIK 1506916 · Co-Chief Executive Officer · last filed 2026-09-11
Jeffrey A Meckler is a Co-Chief Executive Officer who has filed 59 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing, for TVTX, was dated Sep 11, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.5M across reported positions. 11 SEC filings were submitted jointly with QLT INC/BC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TVTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Director | 101,500 | $53.27 | $5.41M | -$2.27M | 9 | 2026-09-11 |
| INDP | Co-Chief Executive Officer | 229,929 | $2.21 | $508.1K | $273.6K | 17 | 2026-02-13 |
| Intec Pharma Ltd. (NTEC) Delisted | Chief Executive Officer | 9,838 | $9.63 | $94.7K | $59.3K | 4 | 2020-07-17 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 64,000 | — | — | $350.1K | 10 | 2020-05-19 |
| QLTI | Director | 94,500 | $26.88 | $2.54M | $362.0K | 10 | 2016-06-21 |
Recent Filings
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-11 | TVTX | Mixed | — | -$906.5K | EDGAR |
| 2026-09-10 | TVTX | Notice (144) | −20,000 | -$1.32M | EDGAR |
| 2026-05-21 | TVTX | Grant (A) | +4,000 | $0 | EDGAR |
| 2026-05-06 | TVTX | Mixed | — | -$229.4K | EDGAR |
| 2026-05-04 | TVTX | Notice (144) | −8,000 | -$360.0K | EDGAR |
| 2026-02-13 | INDP | Mixed | — | $0 | EDGAR |
| 2025-12-29 | INDP | Grant (A) | +216,617 | $439.7K | EDGAR |
| 2025-07-29 | INDP | Grant (A) | +6,068 | $50.4K | EDGAR |
| 2025-05-16 | TVTX | Grant (A) | +6,500 | $0 | EDGAR |
| 2025-04-11 | INDP | Disp (D) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.